Term ends Nov 11, 2027 · Low confidence
20-year base term ended Oct 28, 2023
Reissue of US 8,153,066, which was surrendered when this reissue was granted; its term and maintenance fees continue here.
Held by Genewave
Filed Jul 14, 2015 as application 14/799,092 · Granted Sep 27, 2016
Base term plus 1475 days of patent term adjustment (USPTO delay)
Today
2003
2027
Clock starts
Oct 28, 2003
Oct 28, 2003
Term ends
Nov 11, 2027
Nov 11, 2027
Granted
Sep 27, 2016
Sep 27, 2016
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,475
Days of term adjustment
Read from the original patent's USPTO patent term adjustment record, which governs a reissue. Not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from the original patent's grant (Apr 10, 2012). This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1475 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 28, 2003, when application PCT/FR2003/003214, the earliest non-provisional in its chain, was filed (this one was filed Jul 14, 2015) | Oct 28, 2023 | High confidence |
| Continuity chain | A reissue: its term follows the original patent's, with the original's term adjustment | follows the original patent | Medium confidence |
| Patent term adjustment | +1475 days, the original patent's USPTO patent term adjustment record, which governs a reissue (35 U.S.C. 251). This reissue's own record carries none | Nov 11, 2027 | Medium confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 11, 2027 | Low confidence |
This family
| US 8,153,066 | Surrendered on reissue Sep 2016 | Sep 2016 |
| US RE46,165 | this patent Nov 2027 | Nov 2027 |
2 of 3 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 8, 2026 Reel 75462, frame 440 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Royal Bank of Canada, as Collateral Agent | Security Interest |
| Apr 8, 2026 Reel 75926, frame 339 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2027
Term ends Nov 11, 2027. No further fees fall due before then
Note
The 1475 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.